There is evidence that ERβ may also inhibit colon cancer cell growth through autophagy mediated by suppression of the mammalian target of rapamycin (mTOR) through Cyclin-D1 degradation [109,110]. This evidence concerns the gene MTOR and colonic neoplasm.